Your browser doesn't support javascript.
loading
Early modulation of Angiopoietin-2 plasma levels predicts benefit from regorafenib in patients with metastatic colorectal cancer.
Antoniotti, Carlotta; Marmorino, Federica; Boccaccino, Alessandra; Martini, Silvia; Antista, Maria; Rossini, Daniele; Zuco, Valentina; Prisciandaro, Michele; Conca, Veronica; Zucchelli, Gemma; Borelli, Beatrice; Cosentino, Paola; Germani, Marco M; Bosco, Maria F; Carullo, Martina; Vetere, Guglielmo; Moretto, Roberto; Giordano, Mirella; Masi, Gianluca; Pietrantonio, Filippo; Zaffaroni, Nadia; Cremolini, Chiara.
Afiliación
  • Antoniotti C; Unity of Oncology, University Hospital of Pisa, Pisa, Italy; Department of Translational Research and New Technologies in Medicine, University of Pisa, Pisa, Italy.
  • Marmorino F; Unity of Oncology, University Hospital of Pisa, Pisa, Italy; Department of Translational Research and New Technologies in Medicine, University of Pisa, Pisa, Italy.
  • Boccaccino A; Unity of Oncology, University Hospital of Pisa, Pisa, Italy; Department of Translational Research and New Technologies in Medicine, University of Pisa, Pisa, Italy.
  • Martini S; Molecular Pharmacology Unit, Department of Applied Research and Technological Development, National Cancer Institute of Milan, Milan, Italy.
  • Antista M; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.
  • Rossini D; Unity of Oncology, University Hospital of Pisa, Pisa, Italy; Department of Translational Research and New Technologies in Medicine, University of Pisa, Pisa, Italy.
  • Zuco V; Molecular Pharmacology Unit, Department of Applied Research and Technological Development, National Cancer Institute of Milan, Milan, Italy.
  • Prisciandaro M; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.
  • Conca V; Unity of Oncology, University Hospital of Pisa, Pisa, Italy; Department of Translational Research and New Technologies in Medicine, University of Pisa, Pisa, Italy.
  • Zucchelli G; Unity of Oncology, University Hospital of Pisa, Pisa, Italy; Department of Translational Research and New Technologies in Medicine, University of Pisa, Pisa, Italy.
  • Borelli B; Unity of Oncology, University Hospital of Pisa, Pisa, Italy; Department of Translational Research and New Technologies in Medicine, University of Pisa, Pisa, Italy.
  • Cosentino P; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.
  • Germani MM; Unity of Oncology, University Hospital of Pisa, Pisa, Italy; Department of Translational Research and New Technologies in Medicine, University of Pisa, Pisa, Italy.
  • Bosco MF; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.
  • Carullo M; Unity of Oncology, University Hospital of Pisa, Pisa, Italy; Department of Translational Research and New Technologies in Medicine, University of Pisa, Pisa, Italy.
  • Vetere G; Unity of Oncology, University Hospital of Pisa, Pisa, Italy; Department of Translational Research and New Technologies in Medicine, University of Pisa, Pisa, Italy.
  • Moretto R; Unity of Oncology, University Hospital of Pisa, Pisa, Italy; Department of Translational Research and New Technologies in Medicine, University of Pisa, Pisa, Italy.
  • Giordano M; Unity of Oncology, University Hospital of Pisa, Pisa, Italy; Department of Translational Research and New Technologies in Medicine, University of Pisa, Pisa, Italy.
  • Masi G; Unity of Oncology, University Hospital of Pisa, Pisa, Italy; Department of Translational Research and New Technologies in Medicine, University of Pisa, Pisa, Italy.
  • Pietrantonio F; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.
  • Zaffaroni N; Molecular Pharmacology Unit, Department of Applied Research and Technological Development, National Cancer Institute of Milan, Milan, Italy.
  • Cremolini C; Unity of Oncology, University Hospital of Pisa, Pisa, Italy; Department of Translational Research and New Technologies in Medicine, University of Pisa, Pisa, Italy. Electronic address: chiaracremolini@gmail.com.
Eur J Cancer ; 165: 116-124, 2022 04.
Article en En | MEDLINE | ID: mdl-35231767
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias del Recto / Neoplasias Colorrectales / Neoplasias del Colon / Demencia Frontotemporal Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Eur J Cancer Año: 2022 Tipo del documento: Article País de afiliación: Italia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias del Recto / Neoplasias Colorrectales / Neoplasias del Colon / Demencia Frontotemporal Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Eur J Cancer Año: 2022 Tipo del documento: Article País de afiliación: Italia